Trial intelligence / Profile preview

Zonisamide for Veterans with PTSD and Alcohol Dependence

NCT01847469Phase 2Completed

Sponsor
Yale University
Start
Jun 2013
Primary completion
Jan 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of zonisamide in alcohol dependence, post-traumatic stress disorder (PTSD), sponsored by Yale University. Started Jun 2013; status: completed.

02

Drugs

zonisamide
03

Conditions

alcohol dependencepost-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on NCT01847469.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01847469.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call